RIVALIF Trademark

Trademark Overview

On Monday, September 30, 2019, a trademark application was filed for RIVALIF with the United States Patent and Trademark Office. The USPTO has given the RIVALIF trademark a serial number of 79275703. The federal status of this trademark filing is REGISTERED as of Tuesday, December 22, 2020. This trademark is owned by Luye Pharma Switzerland AG. The RIVALIF trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, preparations for the treatment of Alzheimer's disease; transdermal patches for use in the treatment of Alzheimer's disease
rivalif

General Information

Serial Number79275703
Word MarkRIVALIF
Filing DateMonday, September 30, 2019
Status700 - REGISTERED
Status DateTuesday, December 22, 2020
Registration Number6224463
Registration DateTuesday, December 22, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 6, 2020

Trademark Statements

Goods and ServicesPharmaceutical products, namely, preparations for the treatment of Alzheimer's disease; transdermal patches for use in the treatment of Alzheimer's disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 8, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLuye Pharma Switzerland AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameLuye Pharma Switzerland AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameLuye Pharma Switzerland AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events

Event DateEvent Description
Thursday, January 2, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, January 8, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 8, 2020ASSIGNED TO EXAMINER
Tuesday, January 14, 2020APPLICATION FILING RECEIPT MAILED
Wednesday, January 15, 2020ASSIGNED TO EXAMINER
Tuesday, January 28, 2020NON-FINAL ACTION WRITTEN
Wednesday, January 29, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, February 26, 2020REFUSAL PROCESSED BY MPU
Wednesday, February 26, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, March 13, 2020REFUSAL PROCESSED BY IB
Saturday, August 8, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, August 8, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, August 8, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 31, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 16, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 30, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, October 6, 2020PUBLISHED FOR OPPOSITION
Tuesday, October 6, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 22, 2020REGISTERED-PRINCIPAL REGISTER
Monday, January 25, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sunday, February 14, 2021NOTIFICATION PROCESSED BY IB
Monday, March 22, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, March 27, 2021FINAL DISPOSITION PROCESSED
Saturday, March 27, 2021FINAL DISPOSITION NOTICE SENT TO IB
Sunday, April 18, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, December 22, 2025COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

Related Keywords

rivalif disease alzheimer treatment transdermal patches products namely pharmaceutical preparations